HT-002

WHAT IS HT-002?

HT-002 is a novel peptide therapeutic targeted for the treatment of illness associated with SARS-CoV-2 infection (COVID-19 disease). The peptide is also under evaluation for potential prophylactic therapeutic benefits as well.

DEVELOPMENT STATUS

HT-002 is at the preclinical stage of development.

Upcoming Milestones:

EXTERNAL RESOURCES

INVESTOR RELATIONS

Hoth Therapeutics seeks to enhance shareholder value not only through business performance and practices, but also through responsible and effective communication with its shareholders.